John Johnson, Chief Executive Officer at MELINTA THERAPEUTICS, INC. /NEW/ (MLNT), sold 13,000 shares at $5.57 ($72K) on 2019-06-27, disclosed to the SEC on 2019-07-02.
Open-market sale of $72k MLNT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| XERS | SELL | 2025-12-19 | $978K | — | Filing → |
| AXGN | SELL | 2025-12-10 | $2.8M | — | Filing → |
| XERS | SELL | 2025-08-15 | $787K | — | Filing → |